Aurora Kinase Inhibitor III

CAS879127-16-9

Aurora Kinase Inhibitor III (CAS 879127-16-9, C21H18F3N5O) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of Aurora  Kinase  Inhibitor  III
C21H18F3N5O · 413.40 g/mol
CAS No.
879127-16-9
Formula
C21H18F3N5O
Mol. weight
413.40 g/mol

Chemical Specifications

Identifiers

CAS number 879127-16-9
Product name Aurora Kinase Inhibitor III
Synonyms Aurora Kinase Inhibitor III; Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide
Molecular formula C21H18F3N5O
Molecular weight 413.40 g/mol

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of Aurora Kinase Inhibitor III?

The CAS Registry Number of Aurora Kinase Inhibitor III is 879127-16-9. Aurora Kinase Inhibitor III is also known as Aurora Kinase Inhibitor III; Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide.

What is the molecular formula and molecular weight of Aurora Kinase Inhibitor III?

The molecular formula of Aurora Kinase Inhibitor III is C21H18F3N5O, and its molecular weight is 413.40 g/mol.

How can I request a quotation for Aurora Kinase Inhibitor III?

Send an inquiry for Aurora Kinase Inhibitor III (CAS 879127-16-9) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for Aurora Kinase Inhibitor III

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.